In cells exposed to DEHP, SS‑31 pre-treatment, which improved mitochondrial function, decreased the expression of the PERK pathway.
In plain wordsIn cells, SS‑31 improved mitochondrial function and lowered activity of the PERK stress pathway.
- Peptide
- Elamipretide (SS-31)
- Outcome
- DecreasePERK pathway expression after SS-31
- Study
n: not reported in source
- Outcome group
- Receptor activity and mechanism · Reproductive and sexual health
- Studied dose
- Dose not stated
Source sentences
Moreover, the improvement of mitochondrial dysfunction decreased the expression of PERK pathway by using SS-31(a protective agent for mitochondrial function).
1 context sentence(design, population, supporting numbers)
This view has also been confirmed in TM3 and TM4 cells.